Medicine & Life Sciences
Pancreatic Neoplasms
100%
Adenocarcinoma
56%
Neoplasms
55%
gemcitabine
29%
Mutation
25%
Therapeutics
25%
veliparib
23%
Capecitabine
22%
Survival
20%
Poly(ADP-ribose) Polymerase Inhibitors
20%
Maximum Tolerated Dose
17%
Precision Medicine
17%
ixabepilone
17%
Biomarkers
16%
Drug Therapy
16%
utomilumab
15%
Catenins
15%
Safety
14%
pembrolizumab
14%
130-nm albumin-bound paclitaxel
13%
DNA Repair
13%
Breast Neoplasms
12%
Radiosurgery
11%
poly ADP-ribose glycohydrolase
11%
Retinoids
11%
osteoblast cadherin
11%
Fluorouracil
11%
DNA Damage
11%
Cyclin-Dependent Kinase 4
11%
Colorectal Neoplasms
10%
High-Throughput Nucleotide Sequencing
10%
Clinical Trials
9%
Pharmacokinetics
9%
Temozolomide
9%
Circulating MicroRNA
9%
Progression-Free Survival
9%
Cyclin-Dependent Kinases
9%
Cell Line
8%
Platinum
8%
Spectrin
8%
Cyclin D1
8%
Gastrointestinal Neoplasms
8%
Sorafenib
8%
Oxaliplatin
8%
2-chloro-N-(2-(5-(dimethylamino)naphthalene-1-sulfonamido)ethyl)-4-(2-(1-hydroxy-3-methylbutan-2-ylamino)-9-isopropyl-9H-purin-6-ylamino)benzamide
7%
Disease Progression
7%
Hepatocellular Carcinoma
7%
varlilumab
7%
Neuroendocrine Tumors
7%